Serum thyroglobulin predicts thyroid remnant ablation failure with 30 mCi iodine-131 treatment in patients with papillary thyroid carcinoma
M Tamilia, N Al-Kahtani, L Rochon… - Nuclear medicine …, 2011 - journals.lww.com
Background Most patients with differentiated thyroid cancer are treated with radioiodine (131-
I) after thyroidectomy. The characteristics predictive of successful remnant ablation with low …
I) after thyroidectomy. The characteristics predictive of successful remnant ablation with low …
Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen
I Borget, H Remy, J Chevalier, M Ricard, M Allyn… - European Journal of …, 2008 - Springer
Purpose Treatment of thyroid cancer consists of thyroidectomy and radioiodine ablation
following thyroid-stimulating hormone (TSH) stimulation. Similar ablation rates were …
following thyroid-stimulating hormone (TSH) stimulation. Similar ablation rates were …
Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: a cohort study of 740 patients
Background The purpose of this study was to detect parameters that could serve as
predictors of radioactive iodine (I‐131) ablation failure in patients with low‐risk and …
predictors of radioactive iodine (I‐131) ablation failure in patients with low‐risk and …
Recombinant human thyroid stimulating hormone versus thyroid hormone withdrawal for radioactive iodine treatment of differentiated thyroid cancer with nodal …
RM Wolfson, I Rachinsky, D Morrison… - Journal of …, 2016 - Wiley Online Library
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for
preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with …
preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with …
Outpatient thyroid remnant ablation using repeated low 131-iodine activities (740 MBq/20 mCi× 2) in patients with low-risk differentiated thyroid cancer
J Clerc, M Bienvenu-Perrard… - The Journal of …, 2012 - academic.oup.com
Context: In low-risk differentiated thyroid cancer (DTC), postoperative 131I remnant ablation
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
Variations in radioiodine ablation: decision-making after total thyroidectomy
O Maas, F Forrer, M Maas, CM Panje, J Blautzik… - European journal of …, 2020 - Springer
Background The role of radioiodine treatment following total thyroidectomy for differentiated
thyroid cancer is changing. The last major revision of the American Thyroid Association …
thyroid cancer is changing. The last major revision of the American Thyroid Association …
[HTML][HTML] Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta …
I Vardarli, F Weidemann, M Aboukoura, K Herrmann… - BMC cancer, 2020 - Springer
Background Regarding the longer-term recurrence rate the optimal activity for the remnant
thyroid ablation in patients with differentiated thyroid cancer (DTC) is discussed …
thyroid ablation in patients with differentiated thyroid cancer (DTC) is discussed …
Comparison of effective I‐131 half‐life between thyroid hormone withdrawal and recombinant human thyroid‐stimulating hormone for thyroid cancer: A retrospective …
S Grenfell, D Roos, J Rijken, B Higgs… - Journal of Medical …, 2015 - Wiley Online Library
Introduction Preparation for postoperative radioiodine ablation for differentiated thyroid
carcinoma is performed by either thyroid hormone withdrawal or recombinant human thyroid …
carcinoma is performed by either thyroid hormone withdrawal or recombinant human thyroid …
Implication of different clinical and pathological variables in patients with differentiated thyroid cancer on successful ablation for 3700 MBq 131I: a single Egyptian …
ME Husseini - Annals of nuclear medicine, 2016 - Springer
Objective Is to investigate possible factors predicting success of ablation for 3700 MBq
radioactive iodine 131 in patients with differentiated thyroid cancer (DTC) following near …
radioactive iodine 131 in patients with differentiated thyroid cancer (DTC) following near …
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: a …
J Tu, S Wang, Z Huo, Y Lin, X Li, S Wang - Radiotherapy and oncology, 2014 - Elsevier
Background and purpose We conducted a meta-analysis of randomized controlled trials
(RCTs) to compare the effects of recombinant human thyrotropin (rhTSH) and thyroid …
(RCTs) to compare the effects of recombinant human thyrotropin (rhTSH) and thyroid …